Debating animal research was never a particularly central topic throughout my short life so far as a university student. There are the occasional animal activist …
We are excited to announce that CCS has been named a Top 50 Finalist for the 2021 Classy Awards! Classy, which provides information, support and technology for …
Check out CCS’s latest scientific publication on Parkinson’s Disease research. In coordination with the Center for Alternatives to Animal Testing (CAAT), CCS held a workshop May …
CCS is announcing a new partnership with GlassWall Syndicate to provide funding to companies developing alternatives to animal testing. To apply to this funding opportunity, organizations …
Earlier this month, Congressman Alcee Hastings, a Democrat from Florida, died from pancreatic cancer. My heart goes out to Hastings and his family for what …
At the Center for Contemporary Sciences (CCS), we believe in the possibilities that good science can offer. We believe that we can improve human health, and do …
CCS is proud to announce its partnership with the GlassWall Syndicate to help drive investment toward the best, most effective medical research testing methods possible. The GlassWall …
Check out the conversation between CCS President and CEO, Dr. Aysha Akhtar, and Pandemic Punditry co-hosts as they discuss how animal testing is outdated and unsuccessful. …
CCS Intern, Syama Patel, and Fellow, Mikalah Singer had a virtual “sit-down” with Dr. Kristen O’Halloran Cardinal from California Polytechnic State University. Dr. O’Halloran Cardinal …
“After Animals” Podcast interviews CCS’s President and CEO, Dr. Aysha Akhtar. She explains why animal testing is unreliable, the urgency for human-specific testing, and how …
The Terasaki Institute for Biomedical Innovation, based in Los Angeles, California, is a multi-disciplinary biomedical research establishment. Focusing on technologies such as microfluidics, organ-on-a-chip, and …
CCS is a nonprofit 501(c)(3) organization. Contributions to CCS are tax deductible to the extent permitted by law. EIN 84-3817744